CA3012214C - Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale - Google Patents

Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale

Info

Publication number
CA3012214C
CA3012214C CA3012214A CA3012214A CA3012214C CA 3012214 C CA3012214 C CA 3012214C CA 3012214 A CA3012214 A CA 3012214A CA 3012214 A CA3012214 A CA 3012214A CA 3012214 C CA3012214 C CA 3012214C
Authority
CA
Canada
Prior art keywords
bacterial strain
use according
composition
inflammatory
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3012214A
Other languages
English (en)
French (fr)
Other versions
CA3012214A1 (fr
Inventor
Philippe Langella
Rebeca Martin Rosique
Luis Bermudez Humaran
Florian CHAIN
Harry SOKOL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Sorbonne Universite
Institut National de Recherche pour lAgriculture lAlimentation et lEnvironnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP, Sorbonne Universite, Institut National de Recherche pour lAgriculture lAlimentation et lEnvironnement filed Critical Assistance Publique Hopitaux de Paris APHP
Publication of CA3012214A1 publication Critical patent/CA3012214A1/fr
Application granted granted Critical
Publication of CA3012214C publication Critical patent/CA3012214C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
CA3012214A 2016-01-25 2017-01-23 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale Active CA3012214C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1650567A FR3046934B1 (fr) 2016-01-25 2016-01-25 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
FR1650567 2016-01-25
PCT/EP2017/051306 WO2017129515A1 (fr) 2016-01-25 2017-01-23 Souche de faecalibacterium prausnitzii cncm 1-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale

Publications (2)

Publication Number Publication Date
CA3012214A1 CA3012214A1 (fr) 2017-08-03
CA3012214C true CA3012214C (fr) 2024-09-17

Family

ID=55862967

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3012214A Active CA3012214C (fr) 2016-01-25 2017-01-23 Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale

Country Status (17)

Country Link
US (1) US10918678B2 (cg-RX-API-DMAC7.html)
EP (1) EP3407902B1 (cg-RX-API-DMAC7.html)
JP (1) JP6935632B2 (cg-RX-API-DMAC7.html)
CN (1) CN109310714A (cg-RX-API-DMAC7.html)
AU (1) AU2017211244B2 (cg-RX-API-DMAC7.html)
CA (1) CA3012214C (cg-RX-API-DMAC7.html)
ES (1) ES2820338T3 (cg-RX-API-DMAC7.html)
FR (1) FR3046934B1 (cg-RX-API-DMAC7.html)
HU (1) HUE050810T2 (cg-RX-API-DMAC7.html)
IL (1) IL260752B (cg-RX-API-DMAC7.html)
LT (1) LT3407902T (cg-RX-API-DMAC7.html)
NZ (1) NZ744528A (cg-RX-API-DMAC7.html)
PL (1) PL3407902T3 (cg-RX-API-DMAC7.html)
PT (1) PT3407902T (cg-RX-API-DMAC7.html)
SG (1) SG11201806361PA (cg-RX-API-DMAC7.html)
WO (1) WO2017129515A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201805302B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010412B2 (en) * 2011-07-27 2018-07-03 Edwards Lifesciences Corporation Conical crimper
MY201921A (en) * 2017-06-16 2024-03-23 Biofermin Pharmaceutical Co Ltd Agent for preventing or treating fat-associated diseases and/or inflammation
FR3084255B1 (fr) * 2018-07-26 2020-07-03 Institut National De La Recherche Agronomique (Inra) Souche de streptococcus thermophilus cnrz160 pour le traitement et la prevention de l'inflammation intestinale et des desordres associes, chez un individu
FR3099053B1 (fr) * 2019-07-24 2023-01-20 Inst Nat De La Rech Agronomique Inra Souches bacteriennes pour le traitement et la prevention d’une inflammation gastro-intestinale
EP3838276A1 (en) * 2019-12-17 2021-06-23 Exeliom Biosciences Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation
KR102169794B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
KR102169795B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도
CN116056717A (zh) * 2020-07-13 2023-05-02 亚洲大学校产学协力团 用于预防或治疗炎性肠病的组合物
US20230293600A1 (en) * 2020-08-14 2023-09-21 Kobiolabs, Inc. Faecalibacterium prausnitzii strain and uses there of
WO2022065957A1 (ko) * 2020-09-28 2022-03-31 주식회사 천랩 미생물을 포함하는 염증성 질환 진단 또는 치료용 조성물
CN112402459B (zh) * 2020-10-27 2023-01-31 江南大学 普拉梭菌缓解过敏性哮喘和鼻炎Th2反应中的应用
KR102245415B1 (ko) * 2020-12-14 2021-04-29 주식회사 엔테로바이옴 피칼리박테리움 프로스니치 균주 배양 배지 조성물
EP4166150A1 (en) 2021-10-15 2023-04-19 Exeliom Biosciences Association of a faecalibacterium prausnitzii strain and anti-pd-1, anti-pd-l1 or anti-ctla-4 antibodies for the treatment of cancer
EP4389134A1 (en) * 2022-12-20 2024-06-26 Exeliom Biosciences Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection
CN118845848B (zh) * 2024-07-01 2025-10-17 温州大学 普氏粪杆菌dsm 17677在制备防治猪流行性腹泻病毒感染产品中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014137211A1 (en) * 2013-03-05 2014-09-12 Rijksuniversiteit Groningen Use of faecali bacterium prausnitzii htf-f (dsm 26943) to suppress inflammation.
US20190381115A1 (en) * 2014-11-13 2019-12-19 Institut National De La Recherche Agronomique (Inra) Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain

Also Published As

Publication number Publication date
ES2820338T3 (es) 2021-04-20
EP3407902B1 (fr) 2020-07-15
PL3407902T3 (pl) 2021-04-06
NZ744528A (en) 2020-02-28
SG11201806361PA (en) 2018-08-30
US10918678B2 (en) 2021-02-16
LT3407902T (lt) 2020-12-28
CN109310714A (zh) 2019-02-05
CA3012214A1 (fr) 2017-08-03
JP2019508486A (ja) 2019-03-28
AU2017211244A1 (en) 2018-08-09
JP6935632B2 (ja) 2021-09-15
IL260752B (en) 2021-02-28
ZA201805302B (en) 2019-10-30
WO2017129515A1 (fr) 2017-08-03
EP3407902A1 (fr) 2018-12-05
BR112018015121A2 (pt) 2018-12-11
PT3407902T (pt) 2020-09-03
FR3046934A1 (fr) 2017-07-28
AU2017211244B2 (en) 2019-05-16
FR3046934B1 (fr) 2018-01-26
HUE050810T2 (hu) 2021-01-28
US20190030089A1 (en) 2019-01-31

Similar Documents

Publication Publication Date Title
CA3012214C (fr) Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale
CA2709850C (fr) Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures
EP3937958A1 (fr) <smallcaps/>? ? ?christensenellacées? ? ? ? ?bacterie de la famille desdans la prevention et/ou le traitement de maladies inflammatoires chroniques et/ou de maladies gastro-intestinales inflammatoires et/ou de cancers
EP2931289B1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
EP3826655B1 (fr) Souche de streptococcus thermophilius cnrz160 pour le traitement et la prévention de l'inflammation intestinale et des désordres associés, chez un individu
CA3132239A1 (fr) Bacterie de la famille des christensenellacees dans la prevention et/ou le traitement de maladies inflammatoires chroniques et/ou de maladies gastro-intestinales inflammatoires et/ou de cancers
CN110312510A (zh) 肌纤维化抑制用组合物
WO2021013944A1 (fr) Souches bacteriennes de faecalibacterium prausnitzii et de christensenella pour le traitement et la prevention d'une inflammation gastro-intestinale
CA3177937A1 (fr) Compositions et combinaisons destinees aux sujets souffrant d'endometriose
EP3021858B1 (fr) Souche cu1 pour traitement et/ou prevention d'un rhumatisme inflammatoire chronique
WO2020178391A1 (fr) Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
FR3099054A1 (fr) Souche de Christensenella pour son utilisation dans le traitement et la prévention d’une inflammation gastro-intestinale
FR3158224A1 (fr) Effet bénéfique d’une bactérie probiotique Bacillus subtilis dans la lutte contre les infections
Das et al. Impact of Nutraceuticals on Gut Microbiota for the Management of Inflammatory Bowel Disease
HK40000146B (en) Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation
HK40000146A (en) Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation
FR3153743A1 (fr) Effet bénéfique d’une bactérie probiotique Bacillus subtilis sur l’inflammation de bas grade
WO2020245057A1 (fr) Composition comprenant une levure pour la prevention de la cystite simple et/ou recidivante

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20211213

EEER Examination request

Effective date: 20211213

EEER Examination request

Effective date: 20211213

EEER Examination request

Effective date: 20211213

EEER Examination request

Effective date: 20211213

EEER Examination request

Effective date: 20211213

EEER Examination request

Effective date: 20211213

EEER Examination request

Effective date: 20211213